期刊文献+

吉姆单抗/奥唑米星治疗急性早幼粒细胞白血病临床研究进展

下载PDF
导出
出处 《临床血液学杂志》 CAS 2010年第3期311-314,共4页 Journal of Clinical Hematology
  • 相关文献

参考文献20

  • 1王振义.急性早幼粒细胞白血病的维甲酸治疗[M]∥陆道培.白血病治疗学.北京:科学出版社.1992:152.
  • 2WANG Z Y, CHEN Z. Acute promyelocytic leukemia: from highly fatal to highly curable[J]. Blood, 2008, 111:2505-2515.
  • 3SANZ M A, GRIMWADE D, TALLMAN M S, et al Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European Leukemia Net[J]. Blood, 2009, 113: 1875- 1891.
  • 4SIEVERS E L, LARSON R A, STADTMAUER E A, et al. Efficacy and safety of gemtuzumab ozogamiein in patients with CD33-positive acute myeloid leukemia in first relapse[J]. J Clin Oncol, 2001, 19: 3244- 3254.
  • 5VAN DE LOOSDRECHT A A,HUIJGENS P C,OSSENKOPPELE G J. Emerging antibody-targeted therapy in leukemia and lymphoma: current concepts and clinical implications[J]. Anti Cancer Drugs, 2004,15 : 189-201.
  • 6WALTER R B,RADEN B W,KAMIKURA D M,et al. Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity[J]. Blood, 2005,105 : 1295 - 1302.
  • 7AMADORI S. New agents for the treatment of acute myeloid leukemia:gemtuzumab ozogamicin[J]. Hematol Meeting Reports, 2008,2 : 69 - 71.
  • 8JEDEMA I, BARGE R M, VAN DER VELDEN V H, et al. Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity[J]. Leukemia, 2004,18: 316 - 325.
  • 9ESTEY E H, GILES F J, BERAN M, et al. Experience with gemtuzumab ozogamycin ("mylotarg") and alltrans retinoic acid in untreated acute promyelocytic leukemia[J]. Blood,2002,99 : 4222 -4224.
  • 10RAVANDI F, ESTEY E, JONES D, et al. Effective treatment of acute promyelocytic leukemia with alltrans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin[J].J Clin Oncol, 2009,27 : 504- 510.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部